Meredith Cook
Consejero General en ANI PHARMACEUTICALS, INC. .
Fortuna: 4 M $ al 30/04/2024
Cargos activos de Meredith Cook
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANI PHARMACEUTICALS, INC. | Consejero General | 18/07/2022 | - |
| Secretario Corporativo | 18/07/2022 | - |
Historial de carrera de Meredith Cook
Antiguos cargos conocidos de Meredith Cook.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Formación de Meredith Cook.
| Princeton University | Undergraduate Degree |
| Tulane University Law School | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| General Counsel | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Meredith Cook
- Experiencia
